indoramin
This page covers all indoramin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting D(4) dopamine receptor, Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor.
Targets
D(4) dopamine receptor, Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor
Marketed (1)
- Wy21901 · Hematology
Patent intelligence
- indoramin patent landscape — aggregated cliff calendar, attackable patents, originator estates